BRIEF

on DIAGNOSTIC MEDICAL (EPA:ALDMS)

Dynamic growth for DMS Group in 2024

Stock price chart of DIAGNOSTIC MEDICAL (EPA:ALDMS) showing fluctuations.

In 2024, DMS Group, specializing in medical imaging, announces a turnover of €46.1 million, an increase of 9% compared to 2023. This growth is driven by digital radiology and bone densitometry, with a respective increase of 8% and 12%.

International sales, supported by the PLATINUM NEO product, are growing strongly, especially in Asia. At the same time, DMS continues to invest in the development of new solutions, such as the recently awarded Onyx mobile radiology system.

The group anticipates another year of strong growth in 2025, supported by its recent international agreements, particularly in the United States and Denmark.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DIAGNOSTIC MEDICAL news